End Taxpayer Funding of Gender Experimentation Act of 2023

This bill prohibits federal funding - including Medicaid, ACA subsidies, and other federal health programs - from covering gender transition procedures. It specifically bans taxpayer dollars from being used for medical services like hormone therapy, surgery, or puberty-blocking drugs related to gender transition, except for cases involving disorders of sex development or complications from such procedures (as defined in Section 306). The bill also clarifies that ACA premium credits and cost-sharing reductions cannot apply to health plans covering these procedures, though individuals or states may purchase separate non-federal coverage for them. It directly affects federal health programs and beneficiaries relying on government-funded healthcare.